Clinical trial

Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium…

NCT00140517 · London School of Hygiene and Tropical Medicine, Other · Completed

Key facts

NCT number NCT00140517
Title Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
Official title Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
Lead sponsor London School of Hygiene and Tropical Medicine, Other
Collaborators DBL -Institute for Health Research and Development
Status Completed
Study type Interventional
Conditions Malaria in Pregnancy, Birth Weight, Anaemia
Intervention type Drug
Interventions sulphadoxine-pyrimethamine, chloroquine
Enrollment 700
Start date Oct 1, 2002
Primary completion Jun 1, 2007
Completion Mar 1, 2008
First posted Sep 1, 2005
Last update posted Jan 12, 2017
Countries Burkina Faso

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies